The different outcomes between breast-conserving surgery plus radiotherapy and mastectomy in metaplastic breast cancer: A population-based study
Authors:
Open Access
- 2 September 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (9) , e0256893
Abstract
Background: Metaplastic breast cancer (MBC) are rare. The survival outcomes of MBC patients after breast conserving surgery plus radiotherapy (BCS+RT) or mastectomy have not been established. The study aimed to compare survival outcomes of MBC patients subjected to BCS+RT or mastectomy therapeutic options. Methods: Patients who were subjected to BCS+RT or mastectomy between 2004 and 2014 were enrolled in this study through the Surveillance, Epidemiology and End Results (SEER) database. Breast cancer-specific survival (BCSS) and the overall survival (OS) of the participants were determined. Cox proportional hazard model and the Kaplan Meier method were used to determine the correlation between the two surgical methods and survival outcomes. Results: A total of 1197 patients were enrolled in this study. Among them, 439 patients were subjected to BCS+RT, while 758 patients were subjected to mastectomy. After propensity score matching (PSM), the BCS+RT and mastectomy groups consisted of 321 patients, respectively. The univariate and multivariate analysis with a 6-month landmark all indicate that patients receiving BCS+RT has higher OS than patients receiving mastectomy (HR = 0.701,95% CI = 0.496–0.990, P = 0.044; HR = 0.684,95% CI = 0.479–0.977, P = 0.037) while the BCSS was no difference between the two groups (HR = 0.739,95% CI = 0.474–1.153, P = 0.183; HR = 0.741,95% CI = 0.468–1.173, P = 0.200). Conclusion: The BCS+RT therapeutic option exhibits a higher OS in MBC patients compared to the mastectomy approach.Keywords
All Related Versions
This publication has 32 references indexed in Scilit:
- Metaplastic breast cancer: clinicopathological features and its prognosisJournal of Clinical Pathology, 2012
- Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trialsThe Lancet, 2011
- Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern eraBreast Cancer Research and Treatment, 2011
- Metaplastic Breast Cancer: To Radiate or Not to Radiate?Annals of Surgical Oncology, 2010
- Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancerBreast Cancer Research and Treatment, 2010
- Characteristics and Treatment of Metaplastic Breast Cancer: Analysis of 892 Cases from the National Cancer Data BaseAnnals of Surgical Oncology, 2006
- Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literatureBreast Cancer Research and Treatment, 2006
- Metaplastic breast cancer: clinical significanceThe American Journal of Surgery, 2006
- Metaplastic carcinoma of the breast: A retrospective reviewInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast CancerNew England Journal of Medicine, 2002